Aurinia Pharmaceuticals Inc. (AUPH)
Market Closed
16 Oct, 08:00 PM
$
16. 51
-0.22
-1.315%
$
2.14B Market Cap
- P/E Ratio
- Div Yield
736,075 Volume
-0.52 Eps
$ 16.73
Previous Close 
Want to track AUPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aurinia Pharmaceuticals Inc. (AUPH) Statistics
Valuation metrics
Market Cap 2.14B
Enterprise value 2.02B
Trailing P/E (ttm) 7.06
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 6.87
Price/Book (mrq) 3.52
Enterprise Value/Revenue 6.49
Enterprise Value/EBITDA 10.74
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 815.59K
Average volume (90 days) 914.52K
Price summary
52-Week low 11.3
52-Week high 19.25
Beta -
50-Day moving average 16.34
200-Day moving average 15.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 23 Oct 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 1.01%
Operating margin 0.48%
Operational effectiveness
Return on assets 0.4%
Return on equity 0.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.41
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 5.42%
Book value per share (mrq) 4.73
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
